InvestorsHub Logo
Followers 4
Posts 656
Boards Moderated 0
Alias Born 01/16/2019

Re: None

Friday, 04/17/2020 8:34:07 AM

Friday, April 17, 2020 8:34:07 AM

Post# of 1761
Digipath to Import & Export Cannabis Genetics via Health Canada R&D License

9:00 am ET April 15, 2020 (Globe Newswire) Print

via NEWMEDIAWIRE -- Digipath, Inc. (OTCQB: DIGP) ("DIGP" or the "Company"), a leading independent analytical testing laboratory, data analytics and technology firm focused on the cannabis and hemp markets, is pleased to report that it has been granted permission to import and export non-psychoactive genetics from Health Canada via the Company's wholly owned subsidiary VSSL Enterprises Ltd.

The import permits will enable the Company to import CBD and CBG seeds and grow them at three sites for the purpose of demonstrating that they are compliant, and to subsequently register them to Health Canada's list of approved cultivars for worldwide export and distribution. It will also allow the Company to import unique Genetics expressing CBG and CBN.
"This permission essentially gives our Company the ability to interact and engage with a global network of companies in the international cannabis economy and to greatly accelerate our penetration into new markets," said Kyle Remenda, CEO, Digipath, Inc. "The company will be growing a variety of approved cultivars under the existing Research and Development license, with an ultimate goal of registering the genetics within the legal framework of Health Canada and to sell them to hemp producers, not only outdoor cannabis cultivations."

MADLONG2029